BACK

Aubrey de Grey

Chief Science Officer at SENS Research Foundation; VP of New Technology Discovery at AgeX Therapeutics

  • 09:40, Tuesday 19th
  • Whistler, Canada

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs, and funds laboratory research dedicated to combating the aging process.

He is also VP of New Technology Discovery at AgeX Therapeutics, a biotechnology startup developing new therapies in the field of biomedical gerontology. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40-50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.

BACK

Aubrey de Grey

Chief Science Officer at SENS Research Foundation; VP of New Technology Discovery at AgeX Therapeutics

  • 09:40, Tuesday 19th
  • Whistler Convention Center

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA Cambridge, UK, and is the Chief Science Officer of SENS Research Foundation, a 501 non-profit charity dedicated to combating the aging process. SENS Research Foundation’s work encompasses the etiology of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (“damage”) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. He has developed a possibly comprehensive plan for such repair, termed Strategies for Engineered Negligible Senescence (SENS).​

Want to see more?